BUSINESS● LOW3h ago · Sep 30, 2026, 10:59 AM
Vanda posts late-stage trial win for HETLIOZ in DSWPD, setting up another label expansion
Seeking Alpha Tech · global
Vanda has achieved a late-stage trial victory for its drug HETLIOZ in treating DSWPD, which positions the company for further label expansion. This indicates progress in pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS32m agoOverseas sericulture trainees vow to promote silk industry in their countriesThe HinduBUSINESS33m agoVanguard Short-Term Bond ETF declares monthly distribution of $0.2680Seeking Alpha Tech